Reboxetine: A Novel Antidepressant

Reboxetine: A Novel Antidepressant

Bibliographic Details
Main Authors:	Kadhe N, Chillar A, Deshmukh Y
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2003-01-01
Series:	Journal of Postgraduate Medicine
Online Access:	http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2003;volume=49;issue=4;spage=373;epage=375;aulast=Kadhe

Similar Items

Behavioral Physiology of Dorsal and Ventral Noradrenergic Bundle in Mediating the Antidepressant Effect of Reboxetine
by: Fang, Tien-Hao, et al.
Published: (2008)

Reboxetine in the light of science and clinical practice
by: Anna Wasik, et al.
Published: (2019-02-01)

The effect of reboxetine in the treatment of depression in children and adolescents
by: Tashakori A., et al.
Published: (2007-10-01)

Spectrophotometric Determination of Reboxetine through Condensation and Diazo-Coupling Reactions
by: K. Srikanth, et al.
Published: (2011-01-01)

Resolution of Ecchymotic Lesions due to Fluoxetine and Escitalopram after Introduction of Reboxetine
by: Sibel Kocbiyik, et al.
Published: (2015-03-01)

Gut Microbiome Alteration after Reboxetine Administration in Type-1 Diabetic Rats
by: Sinem Aydin, et al.
Published: (2021-09-01)

β2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain
by: Ipek Yalcin, et al.
Published: (2009-03-01)

The stereoselective synthesis of iodinated analogues of reboxetine : new imaging agents for the noradrenaline transporter
by: Jobson, Nicola K.
Published: (2009)

Six week open-label reboxetine treatment in children and adolescents with attention deficit hyperactivity disorder
by: Arabgol F, et al.
Published: (2007-10-01)

Effectiveness of reboxetine in treatment of outpatient children and adolescents with attention deficit-hyperactivity disorder with comorbid anxiety disorders.
by: Forough Riahi, et al.
Published: (2013-12-01)

Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial
by: Azarbarzin, A., et al.
Published: (2022)

Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task
by: Liu Yia-Ping, et al.
Published: (2009-08-01)

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
by: Caroline Ann Browne, et al.
Published: (2013-12-01)

Characterisation of a novel antidepressant, Org 34167
by: Slattery, David Anthony
Published: (2003)

Essential Oils and Their Constituents: An Alternative Source for Novel Antidepressants
by: Damião P. de Sousa, et al.
Published: (2017-08-01)

On 'cognitive dysfunction' as a novel target for antidepressant treatment
by: Impey, B., et al.
Published: (2013)

Galanin Receptors as Drug Target for Novel Antidepressants: Review
by: Demsie DG, et al.
Published: (2020-04-01)

Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants
by: Shigeyuki Chaki, et al.
Published: (2019-04-01)

Blonanserin – A Novel Antianxiety and Antidepressant Drug? An Experimental Study
by: Ramchandra Prabhakar Limaye, et al.
Published: (2016-09-01)

Perisynaptic astrocytes as a potential target for novel antidepressant drugs
by: Marcos E. Frizzo, et al.
Published: (2021-01-01)

Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
by: Charles F. Zorumski, et al.
Published: (2019-11-01)

MicroRNA profiling identifies a novel compound with antidepressant properties.
by: Stacy L Sell, et al.
Published: (2019-01-01)

Synthesis and Antidepressant Activity Profile of Some Novel Benzothiazole Derivatives
by: Ümide Demir Özkay, et al.
Published: (2017-09-01)

Elucidation of the molecular mechanism of action of psychoactive substances as novel antidepressants
by: Großert, Alessandra
Published: (2020)

Effects of novel antidepressant drugs on mesenchymal stem cell physiology
by: Letizia Ferroni, et al.
Published: (2019-06-01)

Identification and characterisation of novel antidepressant-responsive genes in mouse brain
by: Ganea, Karin
Published: (2009)

EXPLORING THE CONCEPT OF HUMAN OCT3 INHIBITORS AS A NOVEL CLASS OF ANTIDEPRESSANTS
by: Iyer, Kavita A
Published: (2016)

Adherence to antidepressants
by: Abimbola Farinde
Published: (2013-01-01)

Pharmacogenetics of antidepressants
by: Concetta eCrisafulli, et al.
Published: (2011-02-01)

Effects of Antidepressants
Published: (2012)

Molecular Pharmacology of Antidepressants
by: Ordway, Gregory A.
Published: (2006)

Discovery of a New Biological Target for the Development of a Novel Class of Antidepressant Drugs
by: Ordway, Gregory A.
Published: (2017)

Antidepressants Preclinical, Clinical and Translational Aspects
Published: (2019)

Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators
by: Anderson Camargo, et al.
Published: (2019-06-01)

Chronic Antidepressant Treatment in the Nigrostriatal System: the Impact of Antidepressant-Mediated Neuroplasticity
by: Paumier, Katrina Lee
Published: (2011)

Identification of novel candidate genes involved in individual antidepressant treatment response
by: Labermaier, Christiana
Published: (2015)

Selective serotonin reuptake inhibitors and tricyclic antidepressants : novel immunomodulating agents
by: Gordon, Sevelanne
Published: (2012)

ANTIDEPRESSANT ACTION OF HARMINE HYDROCHLORIDE
by: Zh. S. Nurmaganbetov, et al.
Published: (2015-09-01)

Neurogenesis and the Effect of Antidepressants
by: Philippe Taupin
Published: (2006-01-01)

Neurogenesis and The Effect of Antidepressants
by: Philippe Taupin
Published: (2006-01-01)

Cannot write session to /tmp/vufind_sessions/sess_50crb7ugtke15758sg6hmn1eoi